4.7 Article

Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease

期刊

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
卷 57, 期 8, 页码 861-871

出版社

WILEY
DOI: 10.1111/apt.17399

关键词

abdominal pain; disability; fatigue; inflammatory bowel disease; mediation analysis; randomised controlled trial

向作者/读者索取更多资源

This study aimed to investigate the effectiveness of a CD-tailored cognitive-behavioral and mindfulness intervention (COBMINDEX) in reducing abdominal pain and fatigue in patients with CD, as well as the mediating role of changes in abdominal pain and fatigue on improvements in work productivity and daily activities. The results showed that the intervention group receiving COBMINDEX had significantly lower levels of abdominal pain, fatigue, and impairments in work and daily activities compared to the control group. Furthermore, changes in abdominal pain and fatigue mediated the beneficial effects of COBMINDEX on work productivity and daily activities.
BackgroundChronic abdominal pain and fatigue are characteristics of Crohn's disease (CD) and contribute to functional impairments. AimsTo examine whether CD-tailored cognitive-behavioural and mindfulness intervention (COBMINDEX) is effective in reducing abdominal pain and fatigue in patients with CD and whether changes in abdominal pain and fatigue mediate any beneficial effects of COBMINDEX on impairments in work productivity and daily activities. MethodsThis is a secondary analysis of a parallel-group multicentre randomised controlled trial. Patients with mild-to-moderate CD (n = 142) were randomised into either intervention group receiving COBMINDEX, or control group receiving treatment-as-usual for 3 months followed by COBMINDEX. Complete data were collected from 120 patients (34.0 +/- 10.7 years, 62.5% female, intervention = 60, control = 60). Analysis of covariance assessed group differences in 3-month follow-up scores, controlling for baseline scores. Multiple parallel mediation analysis assessed the proposed mechanisms for the entire sample. ResultsThe intervention group demonstrated significantly lower levels of abdominal pain (F = 17.46, p < 0.001, eta(2)(p) = 0.13), fatigue (F = 7.26, p = 0.008, eta(2)(p) = 0.06) and impairments at work (F = 4.82, p = 0.032, eta(2)(p) = 0.07) and daily activities (F = 6.26, p = 0.014, eta(2)(p) = 0.05), compared with treatment-as-usual. Moreover, changes in abdominal pain and fatigue significantly mediated the beneficial effects of COBMINDEX on patients' work productivity (b = -9.90, SE = 2.86, 95% CI: -16.11 to -4.94) and daily activities (b = -9.65, SE = 1.91, 95% CI: -13.77 to 6.35), independent of changes in disease activity. ConclusionsCOBMINDEX is effective at reducing abdominal pain and fatigue in patients with CD, which in turn leads to improvement in functioning. Clinicians should incorporate screening for severe abdominal pain and fatigue and consider offering cognitive-behavioural and mindfulness training., Number: NCT05085925. Ministry of Health in Israel ().

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据